Key Board Decisions and Financial Results

The Board of Directors met on August 07, 2026 (12:20 IST to 16:10 IST) and approved the following items:

a. Un-audited Financial Results for Q1 FY27:

The Board approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, prepared under Ind AS. The results were reviewed by the statutory auditor, K.P. Rao & Co., who issued an unmodified limited review report.

Standalone Key Figures (₹ in million, except per share data):

  • Revenue from Operations: ₹5,532.25 (Q1 FY27) vs. ₹4,508.22 (Q1 FY26) and ₹6,881.13 (Q4 FY26)
  • Total Income: ₹6,171.72 (Q1 FY27) vs. ₹4,881.09 (Q1 FY26)
  • Profit Before Tax (PBT): ₹1,010.81 (Q1 FY27) vs. ₹687.50 (Q1 FY26)
  • Profit After Tax (PAT): ₹769.12 (Q1 FY27) vs. ₹542.85 (Q1 FY26)
  • Earnings Per Share (EPS) - Basic: ₹11.47 (not annualized)
  • Paid-up Equity Share Capital: ₹670.35 million (67,035,654 shares of ₹10 each)

Consolidated Key Figures (₹ in million, except per share data):

  • Profit After Tax (PAT): ₹564.26 (Q1 FY27)
  • Earnings Per Share (EPS) - Basic: ₹8.42 (not annualized)

The consolidated results include 9 Indian subsidiaries (reviewed) and 3 subsidiaries (unaudited), along with 8 foreign subsidiaries (unaudited). A full list of subsidiaries is provided in Annexure 1.

b. Appointment of Statutory Auditors:

Based on the Audit Committee's recommendation, the Board recommended the appointment of Messrs. Walker Chandiok & Co LLP (Firm Registration No. 001076N/N500013) as the Statutory Auditor. The appointment is for a 5-year term, effective from the conclusion of the 18th Annual General Meeting (FY 2026-27) until the conclusion of the 23rd Annual General Meeting (FY 2031-32), subject to shareholder approval.

This change is proposed as the current auditor, K.P. Rao & Co., will complete their first term at the upcoming AGM. Details are enclosed in Annexure B.

c. Annual General Meeting (AGM):

The Board decided to convene the 18th Annual General Meeting (AGM) on Thursday, September 17, 2026, to be held through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) without a physical venue.

The record date for determining eligibility to vote was fixed as Friday, September 11, 2026.

d. Allotment of ESOP Shares:

The Board approved the allotment of 187,837 equity shares of face value ₹10 each (fully paid-up) to eligible employees upon exercise of options under the Kaynes ESOP Scheme 2022.

  • Exercise Price per share: ₹138
  • Premium per share: ₹128
  • Distinctive Numbers: 67,034,655 to 67,222,491

Capital Impact:

Consequent to this allotment, the company's paid-up equity share capital has increased from ₹67,034,654 (6,703,465 shares) to ₹67,222,491 (6,722,249 shares). The new shares will rank pari-passu with existing equity shares.

The company has received in-principle approval from BSE and NSE for the ESOP scheme and is seeking final listing approvals for the newly allotted shares. Disclosures pursuant to SEBI Regulation 10(c) are enclosed as Annexure C.

Additional Information from Financial Notes

  • Exceptional Items: For the year ended March 31, 2026, exceptional items represented the impact of implementing the Revised Labour Code.
  • IPO Details: The company completed its IPO in November 2022, issuing 14,613,624 shares at ₹587 per share and a pre-IPO placement of 2,338,760 shares at ₹555.85 per share. Total IPO expenses were ₹547.97 million.
  • QIP Issuances: The company raised capital through two QIPs:
  • December 2023: ₹14,000 million via allotment of 5,775,577 shares at ₹2,424 per share.
  • June 2025: ₹16,000 million via allotment of 2,872,788 shares at ₹5,569.50 per share.

Detailed utilization of proceeds for both IPO and QIPs is provided in the notes.

  • Primary Business Segment: The Group primarily operates in the Electronics System Design and Manufacturing (ESDM) segment.

Documents Enclosed

  • Annexure A: Un-audited Financial Results with Limited Review Report
  • Annexure B: Disclosure for appointment of Statutory Auditors
  • Annexure C: ESOP allotment disclosure under SEBI Regulation 10(c)

This information is also available on the company's website at www.kaynestechnology.co.in.